Toronto Dominion Bank Has $31.70 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Toronto Dominion Bank lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 13.6% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 98,680 shares of the company’s stock after selling 15,509 shares during the quarter. Toronto Dominion Bank’s holdings in HCA Healthcare were worth $31,704,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its holdings in shares of HCA Healthcare by 58.0% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 37,994 shares of the company’s stock valued at $12,207,000 after buying an additional 13,951 shares in the last quarter. Marshall Wace LLP purchased a new position in HCA Healthcare during the 2nd quarter valued at about $514,000. Bank of Montreal Can lifted its position in shares of HCA Healthcare by 35.9% in the second quarter. Bank of Montreal Can now owns 300,296 shares of the company’s stock worth $102,315,000 after purchasing an additional 79,354 shares in the last quarter. Evergreen Capital Management LLC grew its position in HCA Healthcare by 7.8% during the second quarter. Evergreen Capital Management LLC now owns 1,132 shares of the company’s stock valued at $364,000 after purchasing an additional 82 shares in the last quarter. Finally, Public Sector Pension Investment Board lifted its holdings in shares of HCA Healthcare by 67.8% during the 2nd quarter. Public Sector Pension Investment Board now owns 6,829 shares of the company’s stock valued at $2,194,000 after buying an additional 2,760 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

HCA stock opened at $405.11 on Thursday. The company has a 50 day moving average price of $374.00 and a 200 day moving average price of $341.69. The stock has a market capitalization of $106.10 billion, a PE ratio of 20.19, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $409.42. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue was up 10.3% on a year-over-year basis. During the same period last year, the company earned $4.29 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock valued at $6,407,273 over the last three months. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on HCA. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Monday, August 19th. Leerink Partners upped their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Barclays upped their price target on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Finally, Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.